ScandicNeuro Corp

04/30/2026

The FDA has just approved a wireless brain implant for severe depression—imagine it as your brain’s first true smart upgrade. It takes 20 minutes to implant in an outpatient clinic, and it’s not a bulky medical gadget; it’s even smaller than an AirPod and operates without batteries or wires running through your head.

Brain implant gets FDA clearance for first wireless depression treatment trial, offering battery-free stimulation in 20-minute outpatient procedure.

04/21/2026

Exciting News! Exciting News! April 21, 2026 s11admin Exciting news! Dr. Dobson felt both honored and humbled to be named an inaugural Fellow of the International Neuropsychological Society (INS) at the 2026 INS Annual Conference in Philadelphia, in the company of many distinguished and highly respe...

03/04/2026

In what ways can neuropsychology add value to global clinical trial research?

In what ways can neuropsychology add value to global clinical trial research? In what ways can neuropsychology add value to global clinical trial research? March 4, 2026 s11admin In what ways can neuropsychology add value to global clinical trial research? Neuropsychology supports global clinical tr...

12/31/2025

Happy New Year!
We wish you prosperity and success in the New Year and look forward to an exciting and inspiring 2026!

12/15/2025

A study from the University of Pittsburgh and UPMC Children’s Hospital has identified an epigenetic signature to help track and improve recovery after pediatric traumatic brain injury (TBI). Published in the Journal of Neurotrauma, it’s the first to reveal DNA changes that distinguish children with complicated mild to severe TBI from those with non-neurological injuries.
https://www.health.pitt.edu/news/pitt-study-finds-signature-pediatric-brain-injury

09/05/2025

Scientists have built the first “artificial neuron” made from a metal–organic framework (M*F) that can behave like real brain cells in water by responding to dopamine. Unlike traditional electronic devices, this M*F neuron can carry out brain-like tasks such as learning through synaptic plasticity, sending integrate-and-fire signals, and adjusting its activity based on dopamine levels.

To demonstrate its capabilities, the team utilized the neuron to control a robotic hand. The amount of dopamine present determined how fast and how strongly the hand moved. This breakthrough brings artificial neurons a significant step closer to functioning like biological ones, opening up exciting possibilities for brain-inspired computers, smart biosensors, and advanced prosthetic devices.

This study presents the first metal-organic framework neuron with real neurotransmitter dopamine tunable spikes for neuromorphic engineering.

05/28/2025

04/30/2025

We need to improve mental health at the individual and societal levels. Despite progress in awareness and destigmatization, significant challenges remain in prevention, access to care, and support for those affected.


https://scandicneuro.com/2025/04/the-need-to-improve-mental-health/

04/28/2025

The field of mental health research is experiencing significant growth in clinical trial activity, with thousands of studies currently investigating treatments for various psychiatric conditions. Read more about the current landscape of mental health clinical trials in this report.

Clinical Trials in Mental Health: Current Landscape and Emerging Approaches Clinical Trials in Mental Health: Current Landscape and Emerging Approaches April 28, 2025 s11admin Clinical Trials in Mental Health: Current Landscape and Emerging Approaches The field of mental health research is experienc...

03/11/2025

Recent research has revealed that long-term use of common over-the-counter pain medications, such as aspirin and ibuprofen, may be associated with a 12% reduction in dementia risk. This finding comes from a study by Erasmus MC University Medical Center Rotterdam researchers, who tracked 11,745 adults over an average of 14.5 years.

The study found that long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) was linked to a decreased risk. In contrast, short-term (less than one month) and intermediate-term (one to 24 months) use showed a slight increase in risk compared to the general population. Cumulative doses without consistent use did not appear beneficial.

Scientists hypothesize that long-term use of these anti-inflammatories may help clear out the accumulation of plaques associated with dementia and Alzheimer's disease. However, it's important to note that long-term use of NSAIDs comes with potential risks, including gastrointestinal bleeding and cardiovascular issues.

Background Non-steroidal anti-inflammatory (NSAID) medication could reduce dementia risk due to anti-inflammatory and possibly amyloid-lowering properties. However, the results of observational stud...

02/14/2025

This small study suggest that vascular changes in brain trauma could trigger Alzheimer’s development. This research proposes a new understanding of neurodegenerative diseases, suggesting that vascular problems may initiate the development of amyloid-related diseases, rather than being a consequence of neuronal damage. In other words, it challenges the current view that brain cell damage comes first, arguing instead that blood vessel dysfunction could be the initial trigger.

Traumatic brain injury (TBI) often leads to impaired regulation of cerebral blood flow, which may be caused by pathological changes of the vascular smooth muscle cells (VSMCs) in the arterial wall. Moreover, these cerebrovascular changes may contribute to the development of various neurodegenerative...